SCHEMBL14927008

SCHEMBL14927008

Cc1cc2cc(-c3cc(-c4ccccc4)cc(-c4ccccc4)c3)nc(Oc3ccccc3)c2cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.43
▸ HTT P42858 2/20 0.43
▸ ABCG2 Q9UNQ0 1/20 0.42
▸ ADORA1 P30542 1/20 0.42
▸ MAPT P10636 6/20 0.41
▸ NPSR1 Q6W5P4 4/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPK1 P28482 2/20 0.40
▸ MCL1 Q07820 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ SQOR Q9Y6N5 1/20 0.39
▸ KMT2A Q03164 6/20 0.39
▸ MEN1 O00255 5/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ CYP2C19 P33261 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16510396 0.89 RAC1 (0.43) LMNAHTTABCG2ADORA1MAPT
SCHEMBL12070583 0.84 RAC1 (0.49) LMNAHTTMAPTKDM4EALDH1A1
SCHEMBL15483493 0.78 SQOR (0.59) LMNAHTTADORA1MAPTNPSR1
SCHEMBL14927078 0.77 L3MBTL1 (0.47) LMNAADORA1MAPTKDM4EALDH1A1
SCHEMBL14927007 0.74 MEN1 (0.43) LMNAMAPTKDM4EALDH1A1HPGD
SCHEMBL14927105 0.72 RAC1 (0.47) MAPTKDM4EALDH1A1GAATDP1
SCHEMBL130007 0.71 RAC1 (0.49) MAPTKDM4EALDH1A1HPGDGAA
SCHEMBL14927010 0.70 PLAU (0.47) HTTMAPTKDM4EALDH1A1KMT2A
SCHEMBL14927081 0.70 L3MBTL1 (0.46) LMNAADORA1MAPTKDM4EALDH1A1
SCHEMBL13757363 0.69 SMN1; SMN2 (0.55) LMNAHTTADORA1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8933096-B2 Antimicrobial agents Rugers, The State University of New Jersey (US) 2015-01-13 — — US disclosed
US-20130116278-A1 ANTIMICROBIAL AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 2013-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116278-A1 ANTIMICROBIAL AGENTS MRPL21, ARG1, RPP30 LMNA 4243/4885HTT 3827/4885ABCG2 148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback